ABCB1 and breast carcinoma: In our previously published study on ABCB1-overexpressing MCF-7/KCR breast cancer cells, we reported the ABCB1 (MDR1 or Pgp)-inhibiting properties of certain steroid derivatives, namely of androstane compounds with aryl-substituted pyrimidines fused to their A-ring.